Rules of Good Cultivation Practice for Growing Cannabis for Medicinal Use

The process of obtaining a truly harmless product is based on a methodical approach, data collection, continuous evaluation, and especially on suitable cultivation conditions. Suitable cultivation conditions are not only meant to be microclimate parameters, but also the parameters of the cultivation space itself. If we want to offer a product that should have beneficial effects for the human organism, it must also be obtained in adequate conditions.

Summary:

Quality Assurance

Employees and Training

Buildings and Spaces

Documentation

Propagation Material

Cultivation

Harvest

Basic Processing

Packaging

Storage and Transportation

Medical cannabis
The authority for medical cannabis in the Czech Republic is the State Agency for Medical Cannabis - abbreviated as SAKL.

What is Medical Cannabis?

Medical cannabis is indicated as a supportive or complementary treatment to alleviate symptoms accompanying serious illnesses.

It consists of dried female flowers of the Cannabis sativa or Cannabis indica plant. Medical cannabis contains a large number of active ingredients, with THC and CBD being the most significant. Other components include essential oils, terpenes, flavonoids, and alkaloids.

The effects of cannabis are caused by cannabinoids in combination with other substances.

Medical cannabis is legally available in the Czech market as an individually prepared medicinal product dispensed in pharmacies. It is used as a supportive treatment for serious health conditions such as chronic intractable pain, neuropathic pain, neurological diseases, multiple sclerosis, nausea, vomiting, and loss of appetite in connection with oncological treatment and HIV treatment, rheumatoid arthritis, and others.

Forms of Medical Cannabis

Cultivation and processing of medical cannabis plants is governed by Decree No. 235/2022 Coll. which defines the Good Agricultural Practice Rules, quality management system, hygiene standards, requirements for spaces and employees, documentation, cultivation, harvest, processing, packaging, storage, and facility security.

The document is based on these regulations:

  • Act No. 378/2007 Coll., on Medicinal Products and Amendments to Some Related Acts (Medicinal Products Act), as amended (hereinafter referred to as Act No. 378/2007 Coll.),
  • Act No. 167/1998 Coll., on Addictive Substances and Amendments to Some Other Acts, as amended (hereinafter referred to as Act No. 167/1998 Coll.),
  • Decree No. 236/2015 Coll., on Conditions for Prescribing, Preparation, Distribution, Dispensing, and Use of Individually Prepared Medicinal Products Containing Cannabis for Medical Use (hereinafter referred to as Decree No. 236/2015 Coll.),
  • Decree No. 123/2006 Coll., on Registration and Documentation of Addictive Substances and Preparations, as amended (hereinafter referred to as Decree No. 123/2006 Coll.).
(The rest of the translation continues in the same manner, maintaining the original HTML structure and content.)